- Home
- ARL vs OABI Comparison
ARL vs OABI Comparison
Compare ARL & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARL
- OABI
- Stock Information
- Founded
- ARL 1999
- OABI 2012
- Country
- ARL United States
- OABI United States
- Employees
- ARL N/A
- OABI N/A
- Industry
- ARL Building operators
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- ARL Real Estate
- OABI Health Care
- Exchange
- ARL Nasdaq
- OABI Nasdaq
- Market Cap
- ARL 233.2M
- OABI 198.2M
- IPO Year
- ARL N/A
- OABI N/A
- Fundamental
- Price
- ARL $14.48
- OABI $1.93
- Analyst Decision
- ARL
- OABI Strong Buy
- Analyst Count
- ARL 0
- OABI 3
- Target Price
- ARL N/A
- OABI $7.00
- AVG Volume (30 Days)
- ARL 3.4K
- OABI 912.8K
- Earning Date
- ARL 08-07-2025
- OABI 08-07-2025
- Dividend Yield
- ARL N/A
- OABI N/A
- EPS Growth
- ARL N/A
- OABI N/A
- EPS
- ARL N/A
- OABI N/A
- Revenue
- ARL $48,234,000.00
- OABI $26,744,000.00
- Revenue This Year
- ARL N/A
- OABI N/A
- Revenue Next Year
- ARL N/A
- OABI $45.65
- P/E Ratio
- ARL N/A
- OABI N/A
- Revenue Growth
- ARL N/A
- OABI 27.07
- 52 Week Low
- ARL $9.43
- OABI $1.22
- 52 Week High
- ARL $22.77
- OABI $4.96
- Technical
- Relative Strength Index (RSI)
- ARL 52.56
- OABI 69.01
- Support Level
- ARL $14.10
- OABI $1.55
- Resistance Level
- ARL $15.71
- OABI $1.73
- Average True Range (ATR)
- ARL 0.54
- OABI 0.10
- MACD
- ARL -0.08
- OABI 0.03
- Stochastic Oscillator
- ARL 33.87
- OABI 100.00
About ARL American Realty Investors Inc.
American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments; the acquisition, development, ownership and management of multifamily properties (Residential); and the acquisition, development, ownership, and management of commercial properties (Commercial), which predominantly comprise office properties. Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.